What 15 Analyst Ratings Have To Say About GoodRx Holdings
Portfolio Pulse from Benzinga Insights
GoodRx Holdings (NASDAQ:GDRX) has received 15 analyst ratings in the last quarter, with 3 bullish, 1 somewhat bullish, and 11 indifferent. The average price target is $8.37, implying an upside from the current price of $6.285. The average price target has increased by 31.6% over the past month.
September 14, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GoodRx Holdings has received mostly indifferent analyst ratings, but the average price target suggests an upside.
The majority of the analyst ratings for GoodRx Holdings are indifferent, indicating uncertainty about the company's performance. However, the average price target is higher than the current price, suggesting that the analysts see potential for the stock price to increase.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100